BSEInsider Trading / SAST6d ago · 29 Jul 2026, 10:11 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

Jupiter Life Line Hospitals Ltd · 543980

✦ AI SummaryPledge

Jupiter Life Line Hospitals Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of a pledge over certain equity shares in favour of Catalyst Trusteeship Limited.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk6/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jupiter Life Line Hospitals Ltd - 543980 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

0503306C_2BB7_4D88_AF8F_E2C3E6549AD9_101121.pdf

pdf

Download →
View document text
CL/SAST/26-27/00735 Date: July 28, 2026 1) National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai – 400051. 2) BSE Limited Floor 25, P. J. Towers, Dalal Street, Mumbai, Mumbai – 400001. 3) Jupiter Life Line Hospitals Limited 1004, 10th Floor, 360 Degree Business Park Maharana Pratap Chowk LBS Marg, Mumbai City, Mulund West, Maharashtra, India, 400080 Dear Sir / Madam, Sub.: Disclosure under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations 2011 in relation to creation of pledge over certain equity shares of Jupiter Life Line Hospitals Limited Pursuant to the disclosure required to be made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the disclosure in respect of the pledged equity shares of Jupiter Life Line Hospitals Limited (“Target Company”) in favour of Catalyst Trusteeship Limited in the capacity of Debenture Trustee for the benefit of Debenture holders. This is for your information and records. Sincerely, For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Encl.: As above ANNEXURE A Format for disclosures under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 Name of the Target Company (TC) Jupiter Life Line Hospitals Limited Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture Concert (PAC) with the acquirer Trustee on behalf of Debenture holders Whether the acquirer belongs to 3 No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the BSE Limited and National Stock Exchange of shares of TC are Listed India Limited % w.r.t. total % w.r.t. total share/voting diluted 5 Details of the acquisition/disposal as follows Number capital share/voting wherever capital of applicable (*) the TC (**) Before the acquisition under consideration, holding of: a) Shares carrying voting rights - - - b) Shares in the nature of encumbrance 33,51,950 5.11 5.11 (pledge/lien/non-disposal undertaking/others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 33,51,950 5.11 5.11 Details of acquisition / sale a) Shares carrying voting rights acquired / sold - - - b) VRs acquired / sold otherwise than by shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold d) Shares Pledged/ encumbered/ invoked/ 1,67,59,750 25.56 25.56 released by the acquirer e) Total (a+b+c+/-d) 1,67,59,750 25.56 25.56 After the acquisition/sale, holding of: a) Shares carrying voting rights - - - b) Shares encumbered with the acquirer (pledge) 2,01,11,700 30.67 30.67 c) VRs otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive - - - shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d) 2,01,11,700 30.67 30.67 Mode of acquisition / disposal / sale (e.g. open market / off market/ public issue/ rights issue/ By way of creation of pledge over shares preferential allotment / inter-se transfer, etc.) Date of acquisition/ disposal / sale of shares /VR or date of receipt of intimation of allotment June 25, 2026 of shares, whichever is applicable. Rs. 13,11,32,044 (6,55,66,022 Equity shares Equity share capital/total voting capital of the having face value of Rs 2 each) TC before the said acquisition/ disposal/ sale Rs. 13,11,32,044 (6,55,66,022 Equity shares Equity share capital/ total voting capital of the having face value of Rs 2 each) TC after the said acquisition/ disposal/ sale Total diluted share/voting capital of the TC Not Applicable after the said acquisition/ disposal Note: (*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signature of the acquirer / seller / Authorised Signatory For Catalyst Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: July 28, 2026